Chris M Kozma

2.5k total citations · 1 hit paper
98 papers, 2.0k citations indexed

About

Chris M Kozma is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Surgery. According to data from OpenAlex, Chris M Kozma has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 13 papers in Economics and Econometrics and 11 papers in Surgery. Recurrent topics in Chris M Kozma's work include Schizophrenia research and treatment (18 papers), Pharmaceutical studies and practices (10 papers) and Medication Adherence and Compliance (10 papers). Chris M Kozma is often cited by papers focused on Schizophrenia research and treatment (18 papers), Pharmaceutical studies and practices (10 papers) and Medication Adherence and Compliance (10 papers). Chris M Kozma collaborates with scholars based in United States, Belgium and Canada. Chris M Kozma's co-authors include Peter J. Weiden, Amy Grogg, Julie Locklear, Terra Slaton, Pat Ray Reese, P. Denys, Brigitte Schurch, Riad Dirani, Rich Barron and Carolyn E. Crump and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Chris M Kozma

91 papers receiving 1.9k citations

Hit Papers

Partial Compliance and Risk of Rehospitalization Among Ca... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia
    2004 519 citations Chris M Kozma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris M Kozma United States 24 880 288 236 214 198 98 2.0k
Shaloo Gupta United States 27 657 0.7× 293 1.0× 284 1.2× 99 0.5× 174 0.9× 81 2.0k
Antoni Sicras‐Mainar Spain 23 319 0.4× 315 1.1× 81 0.3× 362 1.7× 135 0.7× 153 2.0k
George J. Wan United States 25 721 0.8× 214 0.7× 225 1.0× 145 0.7× 197 1.0× 91 2.4k
Ariane K. Kawata United States 20 613 0.7× 220 0.8× 100 0.4× 87 0.4× 117 0.6× 42 1.4k
Marcia F.T. Rupnow United States 28 1.6k 1.8× 410 1.4× 169 0.7× 208 1.0× 10 0.1× 63 2.6k
Amy S. Jeffreys United States 26 299 0.3× 329 1.1× 165 0.7× 87 0.4× 155 0.8× 72 2.2k
Lauren Rayner United Kingdom 21 447 0.5× 147 0.5× 291 1.2× 78 0.4× 684 3.5× 42 2.4k
Ruth Navarro‐Artieda Spain 18 187 0.2× 186 0.6× 45 0.2× 161 0.8× 116 0.6× 106 1.0k
Diana Rofail United States 16 195 0.2× 43 0.1× 118 0.5× 89 0.4× 91 0.5× 43 1.2k
Mark Belger United Kingdom 22 764 0.9× 145 0.5× 204 0.9× 338 1.6× 24 0.1× 83 1.7k

Countries citing papers authored by Chris M Kozma

Since Specialization
Citations

This map shows the geographic impact of Chris M Kozma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris M Kozma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris M Kozma more than expected).

Fields of papers citing papers by Chris M Kozma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris M Kozma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris M Kozma. The network helps show where Chris M Kozma may publish in the future.

Co-authorship network of co-authors of Chris M Kozma

This figure shows the co-authorship network connecting the top 25 collaborators of Chris M Kozma. A scholar is included among the top collaborators of Chris M Kozma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris M Kozma. Chris M Kozma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Chao, Chris M Kozma, Charmi Patel, et al.. (2024). Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia. Journal of Managed Care & Specialty Pharmacy. 30(6). 549–559. 4 indexed citations
2.
3.
Bowen, James D., Chris M Kozma, Megan Grosso, & Amy Phillips. (2018). A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(4). 2453238999–2453238999. 8 indexed citations
4.
Muser, Erik, Chris M Kozma, Carmela Benson, et al.. (2015). Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement. Journal of Medical Economics. 18(8). 637–645. 7 indexed citations
5.
6.
Kozma, Chris M, Erik Muser, & Carmela Benson. (2014). Baseline health resource and criminal justice system costs for clinical trial patients with schizophrenia and prior incareration. Value in Health. 17(3). A218–A218. 1 indexed citations
7.
Kozma, Chris M, Amy Phillips, & Dennis Meletiche. (2014). Use of an Early Disease-Modifying Drug Adherence Measure to Predict Future Adherence in Patients with Multiple Sclerosis. Journal of Managed Care Pharmacy. 20(8). 800–807. 12 indexed citations
8.
Wan, George J., Chris M Kozma, Terra Slaton, William H. Olson, & Brian G. Feagan. (2014). Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy. Journal of Medical Economics. 17(6). 384–393. 24 indexed citations
9.
Virdi, Naunihal, Mehmet Daskiran, S. Nigam, Chris M Kozma, & Praveen Raja. (2012). The Association of Self-Monitoring of Blood Glucose Use with Medication Adherence and Glycemic Control in Patients with Type 2 Diabetes Initiating Non-Insulin Treatment. Diabetes Technology & Therapeutics. 14(9). 790–798. 23 indexed citations
10.
Schurch, Brigitte, P. Denys, Chris M Kozma, et al.. (2007). Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence. European Urology. 52(3). 850–859. 74 indexed citations
11.
Ramaswamy, Krishnan, Chris M Kozma, & Henry A. Nasrallah. (2007). Risk of Diabetic Ketoacidosis after Exposure to Risperidone or Olanzapine. Drug Safety. 30(7). 589–599. 30 indexed citations
12.
13.
Kozma, Chris M, Victoria Barghout, Terra Slaton, Feride Frech, & C. Eugene Reeder. (2002). A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma.. PubMed. 15(9). 40–3, 49. 12 indexed citations
14.
15.
Kozma, Chris M, et al.. (1996). Economic Outcomes for the Treatment of Allergic Rhinitis. PharmacoEconomics. 10(1). 4–13. 17 indexed citations
16.
Gerstenbrand, F, et al.. (1975). [Infusion therapy with mif (melanocyte inhibiting factor) in Parkinson's disease (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 87(24). 822–3. 13 indexed citations
17.
Kozma, Chris M. (1962). [On the demonstration of specific heart antibodies in Chagas myocarditis].. PubMed. 13. 175–80. 3 indexed citations
18.
Kozma, Chris M, et al.. (1961). Observations on the Pathogenesis of Chagas's Disease.. 12(2). 1 indexed citations
19.
Jaffe, Randal C., et al.. (1961). [Remarks on the pathogenesis of Chagas' disease].. PubMed. 12. 137–46. 1 indexed citations
20.
Kozma, Chris M, Ronen Jaffe, & W. G. Jaffé. (1960). [Experimental study of the pathogenesis of myocarditis].. PubMed. 13. 155–61. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaloo Gupta Breakdown of academic impact, for papers by Antoni Sicras‐Mainar Breakdown of academic impact, for papers by George J. Wan Breakdown of academic impact, for papers by Ariane K. Kawata Breakdown of academic impact, for papers by Marcia F.T. Rupnow Breakdown of academic impact, for papers by Amy S. Jeffreys Breakdown of academic impact, for papers by Lauren Rayner Breakdown of academic impact, for papers by Ruth Navarro‐Artieda Breakdown of academic impact, for papers by Diana Rofail Breakdown of academic impact, for papers by Mark Belger
Rankless by CCL
2026